2021, Number 6
<< Back Next >>
Acta Ortop Mex 2021; 35 (6)
Preoperative concentration of plasma fibrinogen as a predictor of bleeding in total hip arthroplasty
Jaime-Romo R, Vidal-Cervantes F, Rivera-Villa A, Colín-Vázquez A
Language: Spanish
References: 21
Page: 507-514
PDF size: 245.12 Kb.
ABSTRACT
Introduction: Total hip arthroplasty is popular for its success in treating coxarthrosis, its associated with substantial blood loss. Significant bleeding causes complications such as increase in hospitalization days, higher costs, exposing the patient to complications associated with blood transfusion. The aim of the study is to investigate the association between preoperative plasma fibrinogen concentration and trans-surgical bleeding and determine fibrinogen level cut-off to present greater trans-surgical bleeding.
Material and methods: Retrospective, observational, analytical study, from June to December 2020, including 227 patients with Kellgren and Lawrence scale IV coxarthrosis undergoing primary total hip arthroplasty, beneficiaries, older than 18 years, without liver or hematological diseases, and history of significant surgical bleeding.
Results: Mean preoperative hemoglobin value was 14.6 ± 1.3 g/dl, after surgery (48 hours) 10.5 ± 1.4 g/dl; decrease of 4.1 ± 1.2 g/dl (p ≤ 0.0001). Mean preoperative hematocrit value 43% [41-45], after the procedure; 32% [29-35]; decrease of 11% [8-14] (p ≤ 0.0001). 98 patients had intraoperative bleeding ≥ 300 ml, 129 had ≤ 300 ml; 61.2% of patients with bleeding greater than 300 ml had fibrinogen values below the cut-off point (388 mg/dl).
Conclusion: In postoperative patients, preoperative fibrinogen levels ≤ 388 mg/dl and age ≥ 58 years were associated with an increased risk of OR = 0.18 (95% CI 0.10-0.32) of presenting trans-surgical bleeding ≥ 300 ml, with a decrease in Hb of 4.1 ± 1.2 g/dl (p = 0.0001) and Hto of 11% [8-14] (p = 0.0001) between the pre and postoperative period in 48 hours.
REFERENCES
Sizer SC, Cherian JJ, Elmallah RDK, Pierce TP, Beaver WB, Mont MA. Predicting blood loss in total knee and hip arthroplasty. Orthop Clin North Am. 2015; 46(4): 445-59.
Song JH, Park JW, Lee YK, Kim IS, Nho JH, Lee KJ, et al. Management of blood loss in hip arthroplasty: Korean hip society current consensus. Hip Pelvis. 2017; 29(2): 81-90.
Berry DJ, Lieberman J. Blood management. En: Surgery of the hip E-book. 2nd ed. Elsevier; 2019, 295-300.
Guler N, Burleson A, Syed D, Banos A, Hopkinson W, Hoppensteadt D, et al. Fibrinolytic dysregulation in total joint arthroplasty patients: Potential clinical implications: potential clinical implications. Clin Appl Thromb Hemost. 2016; 22(4): 372-6.
Fernández-Cortiñas AB, Quintáns-Vázquez JM, Gómez-Suárez F, Murillo OS, Sánchez-López BR, Pena-Gracía JM. Efecto de dosis única intravenosa de ácido tranexámico sobre el sangrado en artroplastía total de cadera. Estudio prospectivo, controlado y aleatorizado. Rev Esp Cir Ortop Traumatol. 2017; 61(5): 289-95.
Healy WL, Iorio R, Clair AJ, Pellegrini VD, Della Valle CJ, Berend KR. Complications of total hip arthroplasty: Standardized list, definitions, and stratification developed by The Hip Society. Clin Orthop Relat Res. 2016; 474(2): 357-364.
Quintero JI, Cárdenas LL, Navas M, Bautista MP, Bonilla GA, Llinás AM, et al. Primary joint arthroplasty surgery: Is the risk of major bleeding higher in elderly patients? A retrospective cohort study. J Arthroplasty. 2016; 31(10): 2264-85.
Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy: fibrinogen: a therapeutic target for bleeding. Transfusion. 2014; 54(5): 1389-405.
Murphy NJ, Eyles JP, Hunter DJ. Hip osteoarthritis: etiopathogenesis and implications for management. Adv Ther. 2016; 33(11): 1921-46.
Cruz-Guerrero RF, Jiménez-Ávila JM, González-Cisneros AC, Rivera-Villa AH, Sánchez-Chávez FA, Rincón-Gómez MR, et al. Starch as a risk factor for increased trans surgical bleeding in total hip arthroplasty. Cir Cir. 2019; 87(2): 164-9.
Song JH, Park JW, Lee YK, Kim IS, Nho JH, Lee KJ, et al. Management of blood loss in hip arthroplasty: Korean hip society current consensus. Hip Pelvis. 2017; 29(2): 81-90.
Aresti N, Kassam J, Nicholas N, Achan P. Hip osteoarthritis. BMJ. 2016; 354: i3405.
Carling MS, Zarhoud J, Jeppsson A, Eriksson BI, Brisby H. Preoperative plasma fibrinogen concentration, factor XIII activity, perioperative bleeding, and transfusions in elective orthopaedic surgery: a prospective observational study. Thromb Res. 2016; 139: 142-7.
Geck MJ, Singh D, Gunn H, Stokes JK, Truumees E. Relationship between preoperative plasma fibrinogen concentration, perioperative bleeding, and transfusions in elective adult spinal deformity correction. Spine Deform. 2019; 7(5): 788-95.
Geck MJ, Singh D, Gunn H, Stokes JK, Truumees E. Is preoperative fibrinogen testing associated with total blood loss in adolescent idiopathic scoliosis correction? Spine Deform. 2017; 5(6): 381-95.
Kim C, Nevitt MC, Niu J, Clancy MM, Lane NE, Link TM, et al. Association of hip pain with radiographic evidence of hip osteoarthritis: diagnostic test study. BMJ. 2015; 351: h5983.
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008; 16(2): 137-62.
Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ, Sevick MA, et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the arthritis, diet, and activity promotion trial. Arthritis Rheum. 2004; 50(5): 1501-10.
Shin H-J, Min B-H, Na H-S. FIBTEM as a predictor of intra- and postoperative blood loss in revision total hip arthroplasty: A prospective observational study. Medicine (Baltimore). 2018; 97(22): 109-29.
Wood RC 3rd, Stewart DW, Slusher L, El-Bazouni H, Cluck D, Freshour J, et al. Retrospective evaluation of postoperative bleeding events in patients receiving rivaroxaban after undergoing total hip and total knee arthroplasty: comparison with clinical trial data. Pharmacotherapy. 2015; 35(7): 663-9.
Matthew J, Devender S, Holly G, Stokes J, Truumees E. Relationship between preoperative plasma fibrinogen concentration, perioperative bleeding, and transfusions in elective adult spinal deformity correction. Spine Deform. 2019; 7: 788-795.
EVIDENCE LEVEL
IV